🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/03/2013 | 42,66 | 42,70 | 41,60 | 42,24 | -0,72% | 2,57% | 27.136.283 |
| 13/03/2013 | 42,50 | 42,68 | 42,44 | 42,55 | -1,00% | 0,56% | 18.781.418 |
| 12/03/2013 | 43,34 | 43,34 | 42,82 | 42,98 | +3,16% | 1,19% | 58.695.860 |
| 11/03/2013 | 40,98 | 41,67 | 40,91 | 41,66 | +1,61% | 1,86% | 40.492.729 |
| 08/03/2013 | 41,41 | 41,51 | 40,95 | 41,00 | -0,69% | 1,34% | 30.678.418 |
| 07/03/2013 | 41,81 | 41,92 | 41,12 | 41,29 | -0,94% | 1,92% | 14.392.813 |
| 06/03/2013 | 41,32 | 41,74 | 41,09 | 41,68 | +0,99% | 1,57% | 19.301.121 |
| 05/03/2013 | 41,60 | 41,65 | 41,13 | 41,27 | -0,21% | 1,26% | 15.843.769 |
| 04/03/2013 | 40,95 | 41,36 | 40,80 | 41,36 | +1,67% | 1,37% | 14.839.890 |
| 01/03/2013 | 40,39 | 40,72 | 40,39 | 40,68 | -0,23% | 0,80% | 15.527.482 |
| 28/02/2013 | 41,04 | 41,23 | 40,77 | 40,77 | -0,56% | 1,12% | 14.893.442 |
| 27/02/2013 | 40,33 | 41,17 | 40,33 | 41,00 | +1,30% | 2,08% | 13.537.121 |
| 26/02/2013 | 40,79 | 40,84 | 40,17 | 40,48 | -0,24% | 1,64% | 14.570.449 |
| 25/02/2013 | 41,33 | 41,46 | 40,56 | 40,57 | -1,05% | 2,17% | 20.338.850 |
| 22/02/2013 | 40,63 | 41,29 | 40,58 | 41,00 | +1,11% | 1,74% | 16.132.807 |
| 21/02/2013 | 40,55 | 40,62 | 40,33 | 40,55 | -0,38% | 0,71% | 12.390.504 |
| 20/02/2013 | 40,42 | 40,79 | 40,29 | 40,71 | +1,04% | 1,25% | 17.607.343 |
| 19/02/2013 | 39,69 | 40,29 | 39,68 | 40,29 | +1,93% | 1,54% | 13.944.793 |
| 15/02/2013 | 39,56 | 39,60 | 39,35 | 39,52 | +0,56% | 0,63% | 16.326.897 |
| 14/02/2013 | 39,16 | 39,33 | 38,96 | 39,30 | +0,10% | 0,95% | 17.116.774 |
| 13/02/2013 | 39,52 | 39,59 | 39,13 | 39,27 | -0,72% | 1,16% | 16.561.858 |
| 12/02/2013 | 39,48 | 39,67 | 39,25 | 39,55 | +0,17% | 1,06% | 10.475.808 |
| 11/02/2013 | 39,30 | 39,60 | 39,21 | 39,48 | +0,49% | 1,00% | 11.959.776 |
| 08/02/2013 | 39,18 | 39,29 | 39,07 | 39,29 | +0,44% | 0,56% | 15.365.566 |
| 07/02/2013 | 39,22 | 39,41 | 39,01 | 39,12 | -0,22% | 1,02% | 16.950.666 |
| 06/02/2013 | 39,46 | 39,55 | 39,10 | 39,21 | -0,82% | 1,14% | 18.218.222 |
| 05/02/2013 | 39,17 | 39,58 | 39,06 | 39,53 | +1,42% | 1,34% | 22.330.050 |
| 04/02/2013 | 39,49 | 39,75 | 38,96 | 38,98 | -2,34% | 2,01% | 30.821.366 |
| 01/02/2013 | 40,31 | 40,79 | 39,61 | 39,91 | -3,28% | 2,94% | 39.497.024 |
| 31/01/2013 | 41,44 | 41,64 | 41,27 | 41,27 | -0,57% | 0,90% | 15.237.291 |